{
  "_id": {
    "$oid": "68633c147a71c91f60eb94f4"
  },
  "code": "1.AA.35",
  "description": "Pharmacotherapy (local), meninges and dura mater of brain",
  "note": [],
  "code_also": [],
  "includes": [
    "Injection of pharmaceutical agent(s), meninges of brain",
    "Instillation, pharmaceutical agent(s), meninges of brain"
  ],
  "excludes": [
    "Systemic pharmacotherapy (see 1.ZZ.35.^^)",
    "that for control of bleeding (see 1.AA.13.^^)"
  ],
  "omit_code": [],
  "attributes": {
    "S": {
      "type": "N/A",
      "codes": []
    },
    "L": {
      "type": "N/A",
      "codes": []
    },
    "E": {
      "type": "N/A",
      "codes": []
    }
  },
  "qualifiers": [
    {
      "code": "1.AA.35.HA-C1",
      "approach": "percutaneous [needle] approach",
      "description": "using antithrombotic agent using percutaneous [needle] approach",
      "includes": [
        "Includes:",
        "warfarin, heparin, enoxaparin,",
        "dipyridamole"
      ]
    },
    {
      "code": "1.AA.35.HH-C1",
      "approach": "percutaneous transcatheter\napproach",
      "description": "using antithrombotic agent using percutaneous transcatheter\napproach",
      "includes": [
        "Includes:",
        "warfarin, heparin, enoxaparin,",
        "dipyridamole"
      ]
    },
    {
      "code": "1.AA.35.HA-1C",
      "approach": "percutaneous [needle] approach",
      "description": "using thrombolytic agent using percutaneous [needle] approach",
      "includes": [
        "Includes:",
        "anistreplase, alteplase,",
        "retaplase, streptokinase,",
        "tenecteplase, TNKase (TNK),",
        "tissue plasminogen activator",
        "(tPA), urokinase"
      ]
    },
    {
      "code": "1.AA.35.HH-1C",
      "approach": "percutaneous transcatheter\napproach",
      "description": "using thrombolytic agent using percutaneous transcatheter\napproach",
      "includes": [
        "Includes:",
        "anistreplase, alteplase,",
        "retaplase, streptokinase,",
        "tenecteplase, TNKase (TNK),",
        "tissue plasminogen activator",
        "(tPA), urokinase"
      ]
    },
    {
      "code": "1.AA.35.HA-K0",
      "approach": "percutaneous [needle] approach",
      "description": "using antiinfective agent NEC using percutaneous [needle] approach",
      "includes": []
    },
    {
      "code": "1.AA.35.HH-K0",
      "approach": "percutaneous transcatheter\napproach",
      "description": "using antiinfective agent NEC using percutaneous transcatheter\napproach",
      "includes": []
    },
    {
      "code": "1.AA.35.HA-M0",
      "approach": "percutaneous [needle] approach",
      "description": "using antineoplastic agent NEC using percutaneous [needle] approach",
      "includes": []
    },
    {
      "code": "1.AA.35.HH-M0",
      "approach": "percutaneous transcatheter\napproach",
      "description": "using antineoplastic agent NEC using percutaneous transcatheter\napproach",
      "includes": []
    },
    {
      "code": "1.AA.35.HA-T9",
      "approach": "percutaneous [needle] approach",
      "description": "using other pharmacological agent NEC using percutaneous [needle] approach",
      "includes": []
    },
    {
      "code": "1.AA.35.HH-T9",
      "approach": "percutaneous transcatheter\napproach",
      "description": "using other pharmacological agent NEC using percutaneous transcatheter\napproach",
      "includes": []
    }
  ],
  "embedding": [
  ]
}